Medical Device News Magazine

Medical Wraps and Bandages Dominate European Market, Expecting 3.36% CAGR by 2028

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The “Europe Medical Tapes & Wraps Market – Focused Insights 2023-2028” report has been added to’s offering.

The European medical tapes & wraps market is poised for substantial growth, with an expected CAGR of 3.64%, reaching $3.46 billion by 2028 from $2.79 billion in 2022. This market analysis report provides comprehensive insights into the European medical tapes & wraps market, covering market size, forecasts, segmentations, and industry trends.

Key Highlights:

  1. UK Dominance: In 2022, the UK emerged as the market leader, accounting for over 21.00% of the European market share. Factors contributing to this dominance include the rising prevalence of chronic diseases, increased road accidents, surgical procedures, and the widespread adoption of surgical tapes within the UK.
  2. Medical Wraps/Bandages Segment: In 2022, the medical wraps/bandages segment held the largest market share at 74.23% and is expected to grow at a CAGR of 3.36% during the forecast period. The demand for medical bandages is on the rise due to the increasing prevalence of chronic diseases and a surge in surgeries and traumas.
  3. Wound Management: The wound management segment, accounting for 45.73% in 2022, is projected to grow at a CAGR of 2.81% during the forecast period. The market’s growth is driven by the rising number of surgical wounds and the increased prevalence of chronic diseases such as cancer, diabetes, and ulcers.
  4. Hospitals Dominate: Hospitals dominated the end-user segment in 2022, holding a share of 36.13%. This segment is expected to grow at a CAGR of 2.88% during the forecast period. The dominance of hospitals can be attributed to their long-term care facilities, surgical arrangements, continuous service availability, and focus on individual health.

Vendors List:

The European medical tapes & wraps market features a wide array of prominent vendors, including:

  • Medline Industries
  • Johnson & Johnson
  • 3M Co.
  • Cardinal Health
  • McKesson
  • Essity AB
  • Integra LifeSciences
  • Smith & Nephew Plc
  • B. Braun Melsungen AG
  • Paul Hartmann AG
  • Nitto Denko Corp (Nitto)
  • Beiersdorf AG
  • Nichiban Co., Ltd.
  • Coloplast A/S
  • Scapa Group plc (Scapa)
  • Milliken & Co
  • Winner Medical Group, Inc.
  • Hollister Inc
  • Avcor Health Care
  • Advancis Medical
  • The ASO Group
  • Dynarex Corp
  • Jiangxi 3L Medical Products Group Co., Ltd.
  • Molnlycke Health Care
  • Seyitler Kimya Sanayi AS
  • ATL Corp
  • DeRoyal Industries, Inc.
  • Dermarite Industries LLC
  • North Coast Medical
  • Libatape Pharmaceutical Co., Ltd.
  • SWM International
  • Lohmann & Rauscher
  • PPI Adhesive Products Ltd
  • Bostik
  • Berry Global
  • Leukoplast Co.
  • Stokvis Tapes
  • KOB GmBH
  • Hy-Tape International
  • KragoTec International
  • Aero Healthcare
  • Sterimed Group
  • Flowstrip International
  • PolarSeal
  • Lamatek Inc
  • BDK Medical
  • FULUO International
  • Ardmel International
  • Urgo Medical
  • Valco Melton
  • Cotek Papers
  • Advanced Medical Products
  • ProTapes
  • CCT Tapes

Product Segmentation & Forecast:

  • Product: Medical Wraps, Medical Tapes
  • Application: Wound Management, Pain Management, Preventive Management, Others
  • End-user: Hospitals, Wound Care Centers, Physician Offices, Ambulance Surgical Centers, Others

For more information about this report visit

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”